Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cleanroom Services Partnership Brings Synergy for Customers

Published: Thursday, May 01, 2014
Last Updated: Thursday, May 01, 2014
Bookmark and Share
Two award-winning laboratory service providers have joined forces to create greater synergy for customers.

Two award-winning laboratory service providers have joined forces to create greater synergy for customers. 


Cleanroom manufacturer Connect2Cleanrooms and specialist laboratory relocation provider Andrew Porter Limited have formed a partnership agreement, which is set to complement and enhance each firm’s service provision. 

Connect2Cleanrooms already provides disassembly, relocation and revalidation of its modular cleanrooms, but the new partnership with Andrew Porter Limited will enable it to offer a full relocation service to include all contents of the cleanroom, such as instrumentation and cold chain materials. 

Relocation of other laboratory spaces outside the cleanroom environment can also be provided, offering customers a turnkey solution. 

Andrew Porter Limited will be able to benefit customers through the partnership by providing modular cleanroom facilities, that could be used temporarily or part of a longer term proposition, for phased moves or where a decant into temporary premises is required as part of a larger relocation. 

This service will further enhance the range of additional services already provided by the company, with Connect2Cleanrooms also assisting Andrew Porter Limited in the training of its operatives to ISO14644-1:1999 EU GGMP, and US Federal standards 209E, where appropriate. 

European sales director at Andrew Porter Limited, John Best, commented: “We have a lot in common with Connect2Cleanrooms. We are both experts in our respective fields and are global companies which are headquartered in Lancashire, UK, so I am really pleased that we will be working together moving forward. 

“The technical specialism we are able to offer to each other’s customers makes this a mutually beneficial partnership that enhances both firms’ service offerings.” 

Joe Govier, managing director of Connect2Cleanrooms, said: “We first met with Andrew Porter Limited when we were both winners at this year’s Red Rose Awards. It is fantastic that the winning did not stop there for either of us and that this partnership will benefit both firms and our customer base now and into the future.” 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Viable HIV Vaccine Confirmed by Study
HIV Study in macaques confirms clinically viable vaccine opening the way for future treatment in humans.
PREVAIL Treatment Trial for Men with Persistent Ebola Viral RNA
The six-month study will enroll 60 to 120 EVD survivors.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Investigational Malaria Vaccine Protects Healthy U.S. Adults
Researchers at NIH have found that the malaria vaccine protected a small number of healthy, malaria-naïve adults in the U.S. from infection for more than one year after immunization.
AACR 2016: Cancer Immunotherapy and Beyond
At this year's meeting there was a palpable buzz around subjects ranging from microbiomics to the tumor microenvironment and cancer vaccines, big data to in vitro and in vivo modeling and drug delivery (to name just a few).
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
Treatment of Common Prostate Cancer
Researchers at UTSW have found that the prostate cancer treatments suppress immune response and may promote relapse.
Cancer Drug Could Treat Blood Vessel Deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!